The active ingredient is prepared per your protocol supervised by your provider and delivered direct to your door
Retatrutide in the Context of Existing GLP-1 Therapy While retatrutide awaits its regulatory moment, the class of incretin-based therapies is far from static
Generally, individuals with a BMI of 30 or above may consider GLP-1 therapy, while those with a BMI between 27 and 29.9, accompanied by related health conditions, also qualify
It stimulates insulin release, reduces glucagon secretion, slows digestion, and decreases appetite
Frequently Asked Questions Our Westlake clinic provides medically supervised weight loss and hormone therapy, including GLP-1 medications such as semaglutide and tirzepatide, HRT, TRT, metabolic testing, advanced lab work, and personalized nutrition coaching